20 January 2025 - IQWiG welcomes the fact that the adjustments to the AMNOG procedure planned for the integration with European law are being made with discretion and that the achievements of the AMNOG are thus to be preserved.

The joint European assessment of health technologies started on 12 January 2025, initially for new drugs for the treatment of cancer and for new drugs for advanced therapy medicinal products. In order to ensure that the European and German benefit assessments are integrated, the Federal Ministry of Health has now presented a draft bill to adapt the national drug benefit assessment regulation. The IQWiG supports the proposed changes. The AMNOG procedure is therefore not to be changed in its basic principles.

Read IQWiG press release